REGISTERED NUMBER: 10899702 (England and Wales)

Financial Statements for the Year Ended 31 August 2025

for

DS Medical Services Limited

Page

Balance Sheet

1

FIXED ASSETS

19,770

18,439

CURRENT ASSETS

135,582

81,236

CREDITORS

Amounts falling due within one year

(136,588

)

(133,705

)

NET CURRENT LIABILITIES

(1,006

)

(52,469

)

TOTAL ASSETS LESS CURRENT LIABILITIES

18,764

(34,030

)

CAPITAL AND RESERVES

18,764

(34,030

)

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

The financial statements are presented in pound sterling (£) which is the functional currency of the company rounded to the nearest pound.

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 6 (2024 - 6 ) .

3.	GOING CONCERN

The company continues to be supported by it directors. They have reviewed the company's financial position and have concluded that it will be able to meet its financial obligations for at least 12 months from the date these financial statements were approved. The financial statements have therefore been prepared on a going concern basis.

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 28 May 2026 and were signed on its behalf by:

Dr D Vishnubala - Director